Literature DB >> 12014370

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura.

Roberto Stasi, Elisa Stipa, Vittorio Forte, Paola Meo, Sergio Amadori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014370     DOI: 10.1182/blood-2002-02-0392

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

Review 1.  Immune thrombocytopenia: no longer 'idiopathic'.

Authors:  Keith McCrae
Journal:  Cleve Clin J Med       Date:  2011-06       Impact factor: 2.321

2.  Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.

Authors:  Aamer Aleem; Ahmed S Alaskar; Farja Algahtani; Mushtaq Rather; Muhamad Hitham Almahayni; Abdulkarim Al-Momen
Journal:  Int J Hematol       Date:  2010-07-17       Impact factor: 2.490

3.  Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.

Authors:  Kiarash Kojouri; James N George
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

4.  Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.

Authors:  P Machado; J M Raya; T Martín; L Morabito; M L Brito; J M Rodríguez-Martín
Journal:  Int J Hematol       Date:  2008-04-15       Impact factor: 2.490

Review 5.  [Adult autoimmune thrombocytopenia: diagnosis and treatment].

Authors:  Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

Review 6.  Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.

Authors:  Claudia Rizzo; Sergio Rizzo; Elisabetta Scirè; Danilo Di Bona; Carlo Ingrassia; Giovanni Franco; Roberto Bono; Gerlando Quintini; Calogero Caruso
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

7.  Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.

Authors:  Yuka Torii; Hiroshi Yagasaki; Hidenori Tanaka; Seiji Mizuno; Nobuhiro Nishio; Hideki Muramatsu; Asahito Hama; Yoshiyuki Takahashi; Seiji Kojima
Journal:  Int J Hematol       Date:  2009-08-07       Impact factor: 2.490

Review 8.  [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"].

Authors:  H Mei; T Dörner
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

Review 9.  Pathophysiology and management of primary immune thrombocytopenia.

Authors:  Hirokazu Kashiwagi; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

10.  Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.

Authors:  Motohiro Kato; Katsuyoshi Koh; Akira Kikuchi; Ryoji Hanada
Journal:  Int J Hematol       Date:  2012-10-27       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.